Our Vision

Many disease and injuries have no current medical approaches capable of restoring lost function. For many patients, their first encounter with a disease or injury brings the difficult realization that, despite major advances in some areas, the medical and pharmaceutical communities offer them limited options.

By focusing on clinical and translational research, we have developed new and innovative methods aimed at improving vision impaired by disease and helping patients affected by a range of neurologic and ophthalmic conditions.

We are committed to treating patients within the framework of clinical studies and publishing our results to help shift the standard of care. Patients considering participation in our trials must understand that individual outcomes cannot be predicted or guaranteed as it is based on age, link of time with the malady, and previous treatment that was done prior to our involvement. Even in conditions where we have demonstrated statistically significant benefits and improvements. Each individual is unique and so is their physiological make up and cellular viability.